These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1001 related items for PubMed ID: 16845660

  • 1. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS, Kumar L, Dinda AK, Dawar R.
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
    Rana C, Sharma S, Agrawal V, Singh U.
    Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
    Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R, Lust JA, Witzig TE, Kyle RA, Greipp PR, Rajkumar SV.
    Bone Marrow Transplant; 2004 Aug; 34(3):235-9. PubMed ID: 15170170
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of bone marrow angiogenesis in multiple myeloma.
    Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR.
    Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR.
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
    Ribas C, Colleoni GW, Silva MR, Carregoza MJ, Bordin JO.
    Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
    [Abstract] [Full Text] [Related]

  • 7. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 8. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression.
    Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K.
    Eur J Haematol; 2004 Jun; 72(6):410-5. PubMed ID: 15128419
    [Abstract] [Full Text] [Related]

  • 9. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.
    Andersen NF, Standal T, Nielsen JL, Heickendorff L, Borset M, Sørensen FB, Abildgaard N.
    Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855
    [Abstract] [Full Text] [Related]

  • 10. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.
    Babarović E, Valković T, Štifter S, Budisavljević I, Seili-Bekafigo I, Duletić-Načinović A, Lučin K, Jonjić N.
    Am J Clin Pathol; 2012 Jun; 137(6):870-8. PubMed ID: 22586045
    [Abstract] [Full Text] [Related]

  • 11. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
    Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M.
    Cancer; 2004 Dec 01; 101(11):2599-604. PubMed ID: 15503306
    [Abstract] [Full Text] [Related]

  • 12. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY.
    BJU Int; 2008 Mar 01; 101(6):758-64. PubMed ID: 18070177
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
    Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Thymara I, Pavlopoulos PM, Terpos E, Stamatopoulos K, Plata E, Anargyrou K, Androulaki A, Davaris P, Yataganas X.
    Leukemia; 2003 Jan 01; 17(1):89-97. PubMed ID: 12529665
    [Abstract] [Full Text] [Related]

  • 14. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
    Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose C.
    Histopathology; 2004 May 01; 44(5):428-36. PubMed ID: 15139990
    [Abstract] [Full Text] [Related]

  • 15. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA.
    Cancer; 2010 Jan 01; 116(1):84-92. PubMed ID: 19862816
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
    Cibeira MT, Rozman M, Segarra M, Lozano E, Rosiñol L, Cid MC, Filella X, Bladé J.
    Cytokine; 2008 Mar 01; 41(3):244-53. PubMed ID: 18178097
    [Abstract] [Full Text] [Related]

  • 17. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L, Kasparová P.
    APMIS; 2008 Dec 01; 116(12):1058-62. PubMed ID: 19133008
    [Abstract] [Full Text] [Related]

  • 18. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A, Ribatti D, Digiesi G.
    Eur J Haematol; 2004 Jul 01; 73(1):36-42. PubMed ID: 15182336
    [Abstract] [Full Text] [Related]

  • 19. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H, Wierzbowska A, Robak T.
    Eur Cytokine Netw; 2003 Jul 01; 14(1):40-51. PubMed ID: 12799213
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.